A promising gene therapy trial, derailed by cancerous side effects in a young patient, is set to reboot with the help of next generation gene-transfer vectors.
A promising gene therapy trial, derailed by cancerous side effects in a young patient, is set to reboot with the help of next generation gene-transfer vectors.
Dustin Rubenstein discusses how the discovery of amoebas that farm their own food links the development of agriculture with the evolution of social behavior.
A snapshot of the highest-ranked articles from a 30-day period on Faculty of 1000
A Duke University researcher survives a sticky situation at a federal research institution to make major strides in determining the genetic roots of Staphylococcus aureus antibiotic resistance.
A snapshot of the highest-ranked articles from a 30-day period on Faculty of 1000
Gabriele Sorci discusses how invaders can band together to more effectively infect hosts.
What substance is supposed to have no effect but can make people feel better, has no chance for a big monetary payoff but is worth billions, and is used in virtually every rigorous clinical trial but has no single, universal formulation? The answer
A snapshot of the highest-ranked articles from a 30-day period on Faculty of 1000